Medicine

Keaton A. Rummel, A. Shakeri, A. Weiss, Allison Magnuson, D. G. Hicks, K. Corbin, Kimberly G. Gergelis

2026.2.1Advances in Radiation Oncology

DOI: 10.1016/j.adro.2026.102012

Abstract

Carcinoma erysipeloides (CE), is a form of cutaneous metastatic disease characterized by invasion of dermis and subcutis by malignant cells through superficial dermal lymphatic vessels1. CE presents with a sharply demarcated erythematous plaque, resembling erysipelas and is difficult to distinguish from infection1,2. Amongst breast cancer patients, CE is rare accounting for only approximately 1-3% of all cutaneous metastases3,4.

Citation format

RUMMEL, Keaton A., et al. Case series of breast carcinoma erysipeloides confined within a prior radiation therapy treatment field. Advances in Radiation Oncology, 2026, 11(6): 102012.